7 March 2018 - A list of drugs and manners of administration that meet the 42 month clock (for a 30% unadjusted price reduction) for the 2018 April cycle have now been published.
Drug/MoAs that meet the 42 month clock will be subject to a 30% unadjusted price reduction (UPR).
Once a drug/MoA has met the 42 month clock, it will be subject to a 30% UPR in each price disclosure cycle thereafter.